Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: committee papers

Table of contents

01 Pre-meeting briefing

02 Company submission

03 NICE clarification Letter

04 Company response to the NICE clarification letter

05 Patient group, submissions AntiCoagulation Europe

06 Patient group, submissions Arrhythmia Alliance

07 Patient group submission AF Association

08 Patient group submission CLOT

09 Professional group submission Royal College of Pathologist

10 Professional group submission UKCPA

11 Expert written personal statements Bakhai

12 Clinical declaration - Khan

13 Patient declaration - WOOD

14 Patient expert statement declaration - HILL

15 Evidence Review Group by Liverpool review implementation group

16 Evidence Review report addendum by Liverpool review implementation group

This page was last updated: 04 August 2015